Top Suppliers:I want be here


459789-99-2

459789-99-2 structure
459789-99-2 structure
  • Name: Obeticholic acid
  • Chemical Name: (4R)-4-[(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
  • CAS Number: 459789-99-2
  • Molecular Formula: C26H44O4
  • Molecular Weight: 420.625
  • Catalog: API Digestive system medication Biliary medicine
  • Create Date: 2018-07-14 09:55:27
  • Modify Date: 2026-07-01 20:26:27
  • INT-747 is a potent and selective farnesoid X receptor (FXR) agonist with an EC50 of 99 nM.

Name (4R)-4-[(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
Synonyms Obticholic acid
6-ECDCA; OBETICHOLIC ACID; INT-747; INT747; 6ALPHA-ETHYL-CHENODEOXYCHOLIC ACID; UNII-0462Z4S4OZ; 459-2; 6-ETHYL-CHENODEOXYCHOLIC ACID
Obeticholic acid 6-ECDCA
INT-747
good supplier 6-Ethylchenodeoxycholic acid,Obeticholic acid with Top quality Factory price
6-Ethylchenodeoxycholicaci
an-24-oic acid
pha,7aL
6α-ethyl-chenodeoxycholic acid
Obeticholic acid(OCA)
6-ECDCA;INT-747;UNII-0462Z4S4OZ;6-ETHYLCHENODEOXYCHOLIC ACID;6ALPHA-ETHYL-CHENODEOXYCHOLIC ACID;OBETICHOLIC ACID;1OSV;CHC
(3α,5β,6α,7α,8ξ)-6-Ethyl-3,7-dihydroxycholan-24-oic acid
INT-747, 6-ECDCA
6-ECDCA
6-Ethylchenodeoxycholic aicd
C15636
Obetichlolic Acid
pha)-6-EthyL
6alpha-Ethyl-chenodeoxycholic acid
Obeticholic Acid : (R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
6-Ecdca
3,7-dihydroxychoL
6-ETHYLCHENODEOXYCHOLIC ACID; OBETICHOLIC ACID; INT 747; INT-747; INT747; 6-ECDCA; OCALIVA
6alph
Obeticholic Acid In-House
Obeticholic Acid(INT 747,6-ECDCA)
Cholan-24-oic acid, 6-ethyl-3,7-dihydroxy-, (3α,5β,6α,7α)
6alpha-ethyl-chenodeoxycholic acid, 6-ECDCA, INT-747
6-Ethylchenodeoxycholic acid
Obeticholic Acid (INT-747)
Obeticholic Acid
Obycholic acid
(3alpha,5beta,6alpha,7alpha)-6-Ethyl-3,7-dihydroxycholan-24
Ocaliva
Obeticholic Acid //BP
3A, 7A -DIHYDROXY-6A -ETHYL-5B-CHOLAN-24-OIC ACID
1osv
6-Ethylchenodeoxycholic acid(Obeticholic Acid)
Obecholic acid
DSP-1747
Obetichloic acid
pha,5beta,6aL
US-DMF No.
6-ECDCA (INT-747), FXR agonist
OCA
6-Ethyl-cdca
2H5]-Obeticholic acid
(R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
Obeticolic acid
Lurasidone (Intermediate ONLY)
(3α,5β,6α,7α)-6-ethyl-3,7-dihydroxy-cholan-24-oic acid
UNII-0462Z4S4OZ
Obeticholic Acid, 10 mM in DMSO
CHC
Description INT-747 is a potent and selective farnesoid X receptor (FXR) agonist with an EC50 of 99 nM.
Related Catalog
Target

EC50: 99 nM (FXR)

In Vitro 6-ECDCA increases the expression of FXR-regulated genes in rat hepatocytes[1]. INT-747 reduces expression of liver JNK-1 and JNK-2[2]. INT-747 (256 μg/mL) shows complete inhibition of bacterial growth in all strains tested. Intestinal permeability remains unaffected after INT-747-addition to an IFN-γ-exposed intestinal epithelium of Caco-2 cells[3].
In Vivo 6-ECDCA (10 mg/kg/day) completely reverted cholestasis induced by E217α. Administration of 6-ECDCA partially prevents the impairment in total bile acid output caused by E217α by increasing the relative abundance of β-MCA and TCDCA and TDCA[1]. INT-747 (10 mg/kg) and HS increases the pulmonary congestion in the animals.INT-747 does not improve renal pathology in the HS-fed animals[2]. INT-747 (5 mg/kg) significantly increases survival in BDL rats. INT-747-treated BDL rats exhibits a significant selective ileal increase in expression of pore-closing claudin-1. Ileal expression of ZO-1 is significantly up-regulated in INT-747-treated BDL rats[3].
Animal Admin Initially, all animals (at 6-weeks age) are placed on a standard rodent diet for a week. Baseline blood and urine samples are collected and basal blood pressure (BP) is measured prior to grouping the animals. Subsequently, the animals are randomized into low (LS; n=9) or high salt (HS) diet groups. Hypertension is induced in the HS group by daily high-salt diet feeding and the group is subdivided to receive one of two doses of INT-747: low dose (10 mg/kg/day; n=15) or high dose (30 mg/kg/day; n=15) in 1% methylcellulose; or vehicle (1% methylcellulose in distilled water; n=15) orally everyday for 6 weeks. In parallel, the LS group also receive 1% methylcellulose. BP is measured weekly for the duration of the study as described below.
References

[1]. Fiorucci S, et al. Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis. J Pharmacol Exp Ther. 2005 May;313(2):604-12.

[2]. Ghebremariam YT, et al. FXR agonist INT-747 upregulates DDAH expression and enhances insulin sensitivity in high-salt fed Dahl rats. PLoS One. 2013 Apr 4;8(4):e60653.

[3]. Verbeke L, et al. The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats. Am J Pathol. 2015 Feb;185(2):409-19.

Density 1.1±0.1 g/cm3
Boiling Point 562.9±25.0 °C at 760 mmHg
Molecular Formula C26H44O4
Molecular Weight 420.625
Flash Point 308.3±19.7 °C
Exact Mass 420.323975
PSA 77.76000
LogP 5.68
Vapour Pressure 0.0±3.5 mmHg at 25°C
Index of Refraction 1.530
Hazard Codes Xi
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.